PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10284649

Using data to evaluate performance.

S DesHarnais·J Chesney·R Wroblewski·S T Fleming
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Data CollectionData Interpretation, StatisticalHospitalsModels, TheoreticalMortalityOutcome and Process Assessment, Health CareQuality of Health CareRiskUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S DesHarnais, J Chesney, R Wroblewski, S T Fleming. 1987. Using data to evaluate performance.. https://pubmed.ncbi.nlm.nih.gov/10284649/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Understanding US addiction physicians' low rate of naltrexone prescription.

Naltrexone was approved by the US Food and Drug Administration (FDA) in December 1994. Although it is one of only two medications for alcohol rehabilitation approved in the US, naltrexone is not frequently prescribed. This paper examines the factors limiting physicians' use of naltrexone. Data were collected through a survey of US physician members of two addiction medicine professional associations. Logistic regression analysis was conducted with the dependent variable being any prescription of naltrexone. Independent variables consisted of physician practice characteristics, physician ratings of naltrexone's attributes (e.g. efficacy), physicians' patient characteristics, and physicians' exposure to information about naltrexone. On average, addiction medicine physicians prescribed naltrexone to 13% of their alcoholism patients. The two main self-reported reasons why physicians did not prescribe the medication to more patients were that patients refused to take the medication or comply with prescribing regimes (23%), and that patients could not afford the medication (21%). Multivariate results indicated that physician perceptions of naltrexone's effectiveness and safety were significantly associated with prescribing. Physicians who had more exposure to information about the product (e.g. by reading more journal articles about naltrexone) were more likely to prescribe it. In summary, multiple factors are contributing to the relatively low naltexone prescription rate.

Data Collection↗
PubMed2003

Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs.

We surveyed resident physicians of 11 primary care programs regarding the management of upper respiratory infections and antibiotic resistance. Although they viewed excess antibiotic use as the most important factor increasing resistance, they had little knowledge regarding antimicrobial resistance and were willing to prescribe antibiotics for common viral illnesses.

Data Collection↗